Kinetic studies and effects in vivo of a new monoamine oxidase inhibitor, N-[2-(o-chlorophenoxy)-ethyl]-cyclopropylamine.

doi:10.1016/0006-2952(68)90184-6

Paper

Kinetic studies and effects in vivo of a new monoamine oxidase inhibitor, N-[2-(o-chlorophenoxy)-ethyl]-cyclopropylamine.

Published Oct 1, 1968 · R. Fuller

Biochemical pharmacology

Q1 SJR score

57

Citations

0

Influential Citations

Full textSemantic Scholar

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

In Vitro Study

Study Snapshot

N-[2-(o-chlorophenoxy)-ethyl]-cyclopropylamine (51641) is a potent inhibitor of monoamine oxidase in vitro and in vivo, increasing serotonin levels in the brain and increasing tryptamine urinary exc

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Kinetic studies and effects in vivo of a new monoamine oxidase inhibitor, N-[2-(o-chlorophenoxy)-ethyl]-cyclopropylamine.

References

Citations